These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6129267)

  • 1. Noncatecholaminergic treatments of tardive dyskinesia.
    Alphs L; Davis JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):380-5. PubMed ID: 6129267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV; Lohr JB; Clark K; Wyatt RJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy in tardive dyskinesia].
    Neumann NU
    Fortschr Med; 1980 Nov; 98(42):1636-40. PubMed ID: 7461556
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV; Wyatt RJ
    Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: nondopaminergic treatment approaches.
    Casey DE
    Psychopharmacology Suppl; 1985; 2():137-44. PubMed ID: 2860657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic treatments for tardive dyskinesia.
    Alphs LD; Davis JM
    Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of a synthetic enkephalin analogue during heroin withdrawal.
    Holmstrand J; Gunne LM
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Mar; 13(2):68-71. PubMed ID: 7437134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Psychopharmacology (Berl); 1979 Apr; 62(2):111-6. PubMed ID: 111273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a synthetic analog of enkephalin on the choreic syndrome].
    Destée A; Petit H; Warot P; Lhermitte F; Agid Y
    Rev Neurol (Paris); 1982; 138(11):845-9. PubMed ID: 6762632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR; Fann WE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
    Morselli PL; Fournier V; Bossi L; Musch B
    Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic influences in tardive dyskinesia.
    Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.